Long-acting medications such as liraglutide, semaglutide, dulaglutide, and exenatide long-acting release, comparatively, boost insulin secretion and decrease glucagon to control postprandial hyperglycemia [1]. This evidence concerns the gene INS and Hyperglycemia.